Estonia Antihypertensive Medicine Sales is set to reach $2.03 Million by 2027 from $1.7 Million 2022, jumped by 11.2% per year. Since 2017, the demand grew 0.1% year on year reaching $1,260 Million.
| # | 10 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 357.2 | 2023 | +0.056% | -0.89% | View data |
| 2 | 2 Italy | 177.4 | 2023 | +1.03% | -3.31% | View data |
| 3 | 3 Australia | 162.2 | 2023 | +10.79% | +13.35% | View data |
| 4 | 4 Austria | 56.8 | 2023 | +0.53% | +1.05% | View data |
| 5 | 5 Sweden | 32.6 | 2023 | +7.95% | +5.04% | View data |
| 7 | 7 Slovenia | 5.2 | 2023 | 0% | +4.87% | View data |
| 8 | 8 Costa Rica | 1.5 | 2023 | +15.38% | +4.56% | View data |
| 9 | 9 Estonia | 1.4 | 2023 | 0% | +3.13% | |
| 10 | 10 Iceland | 0.8 | 2023 | 0% | +9.86% | View data |
